Recursion OS:
The AI platform to industrialize drug discovery

Decoding biology to radically improve lives

As a top biotech — or TechBio — company, we're harnessing new technologies like advanced AI for drug discovery and drug development, supercomputing power, and automation, to build massive fit-for-purpose datasets and state-of-the-art multimodal machine learning foundation models.Our mission is to decode biology, taking a fundamentally different approach to traditional pharma, to design new drugs more efficiently and effectively.
‍
The Recursion Operating System (OS), Recursion's proprietary AI drug discovery and drug development platform, spans target identification to clinical trial enrollment. Every data point we collect along the way is fed back into the drug discovery and drug development platform, improving its performance.